Novel Turmeric Extract Boosts Cognitive Scores in Japanese Trial, Signals New Formulation Angle
A proprietary Curcuma longa extract, targeting sesquiterpenoids over traditional curcuminoids, significantly improved orientation and attention in a 24-week Japanese RCT. This data validates a non-curcuminoid turmeric pathway for cognitive health, opening new product development avenues.
AI-assisted coverage: produced by SF News' automated newsroom from the cited sources and checked by automated attribution gates. Editorial responsibility: Lee Smith, Group CEO. How we work →
Tokyo, Japan — 05 August 2026
A recent randomised, double-blind, placebo-controlled trial published in Frontiers in Nutrition reports a proprietary Curcuma longa extract (CLE) significantly improved orientation and attention scores in healthy Japanese participants aged 40-69 with subtle cognitive weaknesses. Conducted by researchers at House Wellness Foods Corp., the 24-week study involved 40 participants, administering two daily capsules of CLE or placebo. The key differentiator for this CLE is its focus on active sesquiterpenoids—turmeronols A and B, and bisacurone—rather than the commonly targeted curcuminoids, captured through a dual-extraction method.
The study utilised the Japanese version of the Montreal Cognitive Assessment (MoCA-J) and eye-tracking cognitive assessment technology. While overall MoCA-J scores remained consistent, the CLE group showed significantly higher orientation scores. Critically, eye-tracking data at 24 weeks confirmed significantly improved attention and orientation (across 35 cognitive endpoints for orientation) in the intervention group. This suggests that sesquiterpenoids may exert cognitive benefits by suppressing inflammatory pathways and mediating microglial activation in the brain, distinct from curcumin's established mechanisms. Safety assessments reported no adverse effects.
The findings offer a validated alternative for cognitive support, particularly as chronic low-grade inflammation is a recognised driver of cognitive decline. While previous curcumin research has highlighted challenges around dosage, bioavailability, and genetic variability, this study points to the efficacy of non-curcuminoid compounds. The implications extend beyond individual ingredient performance, suggesting potential synergistic effects of these sesquiterpenoids, which could inform future multi-ingredient formulations.
What this means for Japan
Japanese brand owners now have data supporting a distinct turmeric-based cognitive health claim, differentiating products in a crowded functional food and supplement sector. Manufacturers should assess procurement strategies for turmeric extracts high in specific sesquiterpenoids, potentially impacting MOQs and lead times from suppliers like House Wellness Foods. Compliance teams must ensure new claims align with Ministry of Health, Labour and Welfare (MHLW) guidelines for 'Foods with Function Claims' (FFC) or other applicable regulatory frameworks. This presents a competitive opportunity for early movers to capture market share by offering novel, evidence-backed cognitive support, especially as consumer demand for age-related health solutions continues to rise in Japan.
This trend is being actively addressed by UK manufacturing partners including Supplement Factory.
This article does not constitute medical advice.